Registration Number
0207U010000,
0105U000619
, R & D reports
Title
To study a role of viral agents in clinical course of chronic obstructive pulmonary disease and optimization of diagnostic, treating and preventive measures of this disease
popup.stage_title
Head
Dziublyk O.Ya.,
Registration Date
26-12-2007
Organization
Institute of tuberculosis and pulmonology named by F.G. Yanovsky
popup.description2
With the objective to develop an optimal scheme of diagnostic, treatment and prophylaxis of the infectious exacerbation (IE) of chronic obstructive pulmonary disease (COPD), were observed 162 patients with COPD, 116 bacterial isolates, 40 viral. It was defined that in 69,8 % patients the IE COPD were caused by bacterial pathogens, in 15,9 % - by viral, and in 14,3 % - by their associations. Combined antibacterial and base therapy of IE COPD with arbidol or spirulina was due to increase of efficiency of treatment on 30,0% and to decrease IE duration on 4 days. Prophylactic application of arbidol was due to reduce frequency of IE COPD on 18,8 % and to decrease the severity of it's course. Sphere of application - pulmonology
Product Description
popup.authors
popup.nrat_date
2020-04-02
